Role of Toll-Interacting Protein Gene Polymorphisms in Leprosy Mexican Patients

• Published in: BioMed research international 2013-01, Vol.2013 (2013), p.1-7
• Main Authors: Figuera-Villanueva, Luis Eduardo, Padilla-Gutiérrez, Jorge Ramón, Valle, Yeminia, Alvarado-Navarro, Anabell, Tovar-Cuevas, Alvaro J., Fafutis-Morris, M., Montoya-Buelna, Margarita, Muñoz-Valle, Jose F.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biomedical research; Clinical Study; Confidence intervals; Disease; Disease susceptibility; Ethnicity; Female; Gene Frequency; Genes; Genetic aspects; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Immune system; Infections; Intracellular Signaling Peptides and Proteins - genetics; Kinases; Leprosy; Leprosy - genetics; Leprosy - pathology; Linkage Disequilibrium; Male; Mexico; Middle Aged; Polymorphism, Single Nucleotide; Population; Proteins; Risk factors; Single nucleotide polymorphisms; Studies; Toll-Like Receptors - genetics
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2013/459169

Background. Leprosy is a debilitating infectious disease of human skin and nerves. Genetics factors of the host play an important role in the disease susceptibility. Toll-interacting protein (TOLLIP) is an inhibitory adaptor protein within the toll-like receptor (TLR) pathway, which recognizes structurally conserved molecular patterns of microbial pathogens, initiating immune responses. The objective of this study was to investigate the association of variants in the TOLLIP gene with susceptibility to leprosy in Mexican patients. Methods. TOLLIP polymorphisms were studied using a case-control design of Mexican patients with lepromatous leprosy (LL). The polymorphisms of TOLLIP at loci −526 C>G (rs5743854), 1309956C>T (rs3750920), 1298430C>A (rs5744015), and 1292831 G>A (rs3750919) were analyzed by PCR, with sequence-specific primers in LL patients and healthy subjects (HS) as controls. Results. Genotype distributions were in Hardy Weinberg equilibrium for all sites except for rs3750920. Neither genotype nor allele frequencies were statistically different between LL patients and controls (P>0.05). The maximum pairwise D’ coefficient reached was 0.44 of linkage (P=0.01) for all the polymorphisms except for rs5743854. The three loci haplotype comparison yielded no significant differences between groups. Conclusions. Just the individuals with genotype C/C of rs3750920 have a trend of protective effect to developing LL.